kresmion.
Pull a receipt

MIRA Pharmaceuticals, Inc. (MIRA)

Sector
Healthcare
Industry
Drug Manufacturers - General
Last price
$0.57
As of

Kresmion compiles this page from MIRA's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

MIRA PHARMACEUTICALS, INC. (MIRA): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-28.

As of . Source: SEC EDGAR filings for MIRA. Method and limitations.

COMPANY DOSSIER

See the full MIRA dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for MIRA on one page. Preview it with sample data, then open it live with a free account.

Preview the MIRA dossier

Active events for MIRA

FREE, NO ACCOUNT

Every event on MIRA, as it fires

New filings, 13F moves and cross asset events on MIRA land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

MIRA positions held by the managers we follow (2026Q2)

What the managers we follow bought and sold in Q2 2026

Manager / securityMarket value% of reported value
CITADEL ADVISORS LLC FundCUSIP 60458C104 · 2026Q2$18K0.00%

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, MIRA

Going concern statement

MIRA's 10-Q filed Aug 12, 2026 states:

These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of twelve months from the issuance date of this Quarterly Report.

Read the 10-Q on SEC EDGAR Every company with a going concern statement

More data on MIRA

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in MIRA on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on MIRA in the last 180 days.

Upstream: SEC EDGAR filings for MIRA

Kresmion, "MIRA PHARMACEUTICALS, INC. (MIRA) institutional holdings and SEC filings", data as of 2026-10-28, https://kresmion.com/research/MIRA. Upstream data: SEC EDGAR filings for MIRA.

Link to this data (HTML):

<a href="https://kresmion.com/research/MIRA">MIRA PHARMACEUTICALS, INC. (MIRA) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow MIRA on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to MIRA for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the MIRA dossier
Share

The MIRA intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.